<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC3184032/results/search/funders/results.xml">
  <result pre="= cerebrospinal fluid; EBV = Epstein-Barr virus; FDA = US" exact="Food and Drug Administration;" post="HBeAg = hepatitis B e antigen; HBV = hepatitis"/>
  <result pre="in immunocompromised patients.8 Acyclovir is also approved by the US" exact="Food and Drug Administration" post="(FDA) for the treatment of VZV11,12; however, young immunocompetent"/>
  <result pre="resolution of viremia and reduced progression to chronic hepatitis.134,135 The" exact="American Association for the Study of Liver Diseases" post="recommends either IFN-α or peginterferon-α for at least 6"/>
  <result pre="outcome of liver transplantation. Liver Transpl. 2002;8:651-65812149755 68.SpectorSAWeingeistTPollardRBet al.; collab:" exact="AIDS Clinical Trials Group;" post="Cytomegalovirus Cooperative Study GroupA randomized, controlled study of intravenous"/>
 </snippets>
</snippetsTree>
